Related references
Note: Only part of the references are listed.TG2 regulates the heat-shock response by the post-translational modification of HSF1
Federica Rossin et al.
EMBO REPORTS (2018)
Pharmacological aspects of the neuroprotective effects of irreversible MAO-B inhibitors, selegiline and rasagiline, in Parkinson's disease
Eva Szoeko et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Glutathione peroxidase 4-catalyzed reduction of lipid hydroperoxides in membranes: The polar head of membrane phospholipids binds the enzyme and addresses the fatty acid hydroperoxide group toward the redox center
Giorgio Cozza et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
The SH-SY5Y cell line in Parkinson's disease research: a systematic review
Helena Xicoy et al.
MOLECULAR NEURODEGENERATION (2017)
Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs
Rona R. Ramsay et al.
MOLECULES (2017)
Cysteines as Redox Molecular Switches and Targets of Disease
Annamaria Fra et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Emerging role of monoamine oxidase as a therapeutic target for cardiovascular disease
Soni Deshwal et al.
CURRENT OPINION IN PHARMACOLOGY (2017)
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Orly Weinreb et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Drugs related to monoamine oxidase activity
Zdenek Fisar
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity
Giorgio Cozza et al.
BIOCHEMICAL JOURNAL (2015)
Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis
Jason Boyang Wu et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review)
Zhiyou Cai
MOLECULAR MEDICINE REPORTS (2014)
Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: Focus on modulation of CNS monoamine neurotransmitter release
John P. M. Finberg
PHARMACOLOGY & THERAPEUTICS (2014)
Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells
Michael F. Santillo et al.
TOXICOLOGY IN VITRO (2014)
Kinetics and Mechanisms of Thiol-Disulfide Exchange Covering Direct Substitution and Thiol Oxidation-Mediated Pathways
Peter Nagy
ANTIOXIDANTS & REDOX SIGNALING (2013)
Novel polyamine analogues: From substrates towards potential inhibitors of monoamine oxidases
Emanuela Bonaiuto et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Rasagiline and selegiline, inhibitors of type B monoamine oxidase, induce type A monoamine oxidase in human SH-SY5Y cells
Keiko Inaba-Hasegawa et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Synthetic polyamines as potential amine oxidase inhibitors: a preliminary study
Emanuela Bonaiuto et al.
AMINO ACIDS (2012)
Cystamine-tacrine dimer: A new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment
A. Minarini et al.
NEUROPHARMACOLOGY (2012)
Synthetic polyamines: an overview of their multiple biological activities
Anna Minarini et al.
AMINO ACIDS (2010)
Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
Carlo Melchiorre et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Cytotoxicity of methoctramine and methoctramine-related polyamines
Maddalena Zini et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Monoamine oxidase inactivation: From pathophysiology to therapeutics
Marco Bortolato et al.
ADVANCED DRUG DELIVERY REVIEWS (2008)
Monoamine oxidase-A modulates apoptotic cell death induced by staurosporine in human neuroblastoma cells
Julia C. Fitzgerald et al.
JOURNAL OF NEUROCHEMISTRY (2007)
The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines
APB Vintém et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors
F Hubálek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition
MBH Youdim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures
C Binda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structural comparison of human monoamine oxidases A and B -: Mass spectrometry monitoring of cysteine reactivities
F Hubálek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Share Paper
